IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 11 December 2006
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.01424-06v1
75/3/1364    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, J. N.
Right arrow Articles by Heckels, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, J. N.
Right arrow Articles by Heckels, J. E.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.01424-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide deficient mutant

Jeannette N. Williams, Paul J. Skipp, Holly E. Humphries, Myron Christodoulides, C. David O'Connor, and John E. Heckels*

Molecular Microbiology Group, Division of Infection Inflammation and Repair, University of Southampton Medical School, Southampton, UK; Centre for Proteomic Research, School of Biological Sciences, University of Southampton, Southampton, UK

* To whom correspondence should be addressed. Email: jeh{at}soton.ac.uk.


   Abstract

Current experimental vaccines against serogroup B Neisseria meningitidis are based on meningococcal outer membrane (OM) proteins present in vesicles depleted of toxic lipopolysaccharide by detergent extraction (OMV). Knowledge of the composition of OM and OMV is essential for developing new meningococcal vaccines based on defined antigens. In the current study, SDS-PAGE and nanocapillary liquid chromatography- tandem mass spectrometry was used to investigate the proteome of OM and OMV from meningococcal strain MC58, and OM from a lipopolysaccharide-deficient mutant. Analysis of OM revealed a much more complex composition than has previously been reported, with a total of 236 proteins being identified, of which only 6.4% were predicted to be outer membrane-located. The most abundant proteins included not only the well-established major OM proteins (PorA, PorB, Opc, Rmp, Opa) but also other proteins such as pilus-associated protein Q (PilQ) and a putative macrophage infectivity protein (MIP). All of these proteins were also present in OMV obtained by extraction of the OM with deoxycholate. Some additional proteins had markedly increased abundance in OM from the lipopolysaccharide-deficient mutant, including enzymes that contribute to the TCA cycle.

In all the preparations, the proteins not predicted to have an OM location were predominantly periplasmic, cytoplasmic or of unknown location with relatively few cytoplasmic membrane proteins detected. However, several proteins that have previously been identified as potential vaccine candidates were not detected in either OM preparation or in OMV. These results have important implications for the development and use of vaccines based on outer membrane proteins.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2006 by the American Society for Microbiology. All rights reserved.